Company Filing History:
Years Active: 2018-2021
Title: The Innovative Contributions of Adriana Katz
Introduction
Adriana Katz is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of biomedical research, particularly in the development of selective inhibitors for Na,K-ATPase. With a total of 3 patents to her name, her work has the potential to impact treatments for various medical conditions.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure." This patent describes alpha2-selective Na,K-ATPase inhibitors and prodrugs characterized by having a cyclic moiety attached to a digoxin or digitoxin derivative. The applications of this invention are particularly relevant for lowering intraocular pressure and treating conditions such as glaucoma and heart diseases.
Career Highlights
Adriana Katz is associated with Yeda Research and Development Co. Ltd., where she continues to advance her research and innovations. Her work is recognized for its potential to improve therapeutic strategies in the medical field.
Collaborations
Adriana has collaborated with notable colleagues, including Steven J. D. Karlish and Daniel M. Tal. These partnerships have further enriched her research endeavors and contributed to her success as an inventor.
Conclusion
Adriana Katz's innovative work in the field of biomedical research exemplifies the impact of dedicated inventors on healthcare advancements. Her patents reflect a commitment to improving patient outcomes through scientific innovation.